The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

Roche has announced that a tablet formulation of its spinal muscular atrophy (SMA) treatment Evrysdi (risdiplam) has been ...

Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments ...

Finding the right shoes can be tough, but for people who wear braces, the challenge is even bigger. One Murfreesboro man is ...

Lakeside Holding Limited ("Lakeside" or the "Company") , a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized ...

Market OverviewThe Orphan Drugs Market is a specialized sector within the pharmaceutical industry that focuses on the ...

Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Biogen in a research note ...

Biogen (NASDAQ:BIIB – Get Free Report) had its price target decreased by research analysts at The Goldman Sachs Group from $281.00 to $245.00 in a research note issued to investors on ...

Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...

NIH's longtime second-in-command, Larry Tabak, DDS, PhD, was forced to retire from government service. (CBS News) When Robert ...

CR Fitness Holdings LLC, the fastest-growing and leading franchisee of Crunch Fitness, is set to open Crunch Summer Creek, a state-of-the-art, $12 million fitness facility in Fort Worth, Texas.